75 related articles for article (PubMed ID: 24801812)
1. Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma.
Rasmussen JH; Vogelius IR; Fischer BM; Friborg J; Aznar MC; Persson GF; Håkansson K; Kristensen CA; Bentzen SM; Specht L
Head Neck; 2015 Sep; 37(9):1274-81. PubMed ID: 24801812
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Querellou S; Abgral R; Le Roux PY; Nowak E; Valette G; Potard G; Le Duc-Pennec A; Cavarec MB; Marianovski R; Salaün PY
Head Neck; 2012 Apr; 34(4):462-8. PubMed ID: 21604320
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.
Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Naganawa S; Hasegawa Y; Nakashima T
Ann Nucl Med; 2014 May; 28(4):356-62. PubMed ID: 24515867
[TBL] [Abstract][Full Text] [Related]
4. FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Zschaeck S; Löck S; Leger S; Haase R; Bandurska-Luque A; Appold S; Kotzerke J; Zips D; Richter C; Gudziol V; Schreiber A; Zöphel K; Baumann M; Krause M
Radiother Oncol; 2017 Mar; 122(3):437-444. PubMed ID: 28222892
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.
Inokuchi H; Kodaira T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Takada A; Mizoguchi N; Tamaki T; Fuwa N
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):747-55. PubMed ID: 20434274
[TBL] [Abstract][Full Text] [Related]
6. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
de Ridder M; Klop M; Hamming-Vrieze O; de Boer J; Jasperse B; Smit L; Vogel W; van den Brekel M; Al-Mamgani A
Head Neck; 2017 Jul; 39(7):1382-1391. PubMed ID: 28370570
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Lin YC; Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Kao CH
J Nucl Med; 2015 Feb; 56(2):183-9. PubMed ID: 25613534
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment maximum standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography as a predictor of distant metastasis in adenoid cystic carcinoma of the head and neck.
Kim D; Kim W; Lee J; Ki Y; Lee B; Cho K; Kim S; Nam J; Lee J; Kim D
Head Neck; 2016 May; 38(5):755-61. PubMed ID: 25524466
[TBL] [Abstract][Full Text] [Related]
12. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Naitou K; Ueda Y; Ouchi Y
AJR Am J Roentgenol; 2009 Apr; 192(4):W156-60. PubMed ID: 19304675
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H
J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
[TBL] [Abstract][Full Text] [Related]
16. Association between the standardized uptake value and high-risk HPV in hypopharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Lee YS; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
Acta Otolaryngol; 2014 Oct; 134(10):1062-70. PubMed ID: 25220728
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.
Suzuki H; Hasegawa Y; Terada A; Hyodo I; Nakashima T; Nishio M; Tamaki T
Oral Oncol; 2009 Jul; 45(7):569-73. PubMed ID: 18804407
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma.
Rasmussen GB; Håkansson KE; Vogelius IR; Rasmussen JH; Friborg JT; Fischer BM; Schumaker L; Cullen K; Therkildsen MH; Bentzen SM; Specht L
Acta Oncol; 2017 Nov; 56(11):1562-1570. PubMed ID: 28840766
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers.
Sager S; Asa S; Yilmaz M; Uslu L; Vatankulu B; Halaç M; Sönmezoglu K; Kanmaz B
J Cancer Res Ther; 2014; 10(4):922-6. PubMed ID: 25579529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
